Acuta Capital Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Iovance Biotherapeutics
IOVA
|
+$7.54M |
| 2 |
CEMP
Cempra, Inc.
CEMP
|
+$5.12M |
| 3 |
Ascendis Pharma A/S
ASND
|
+$4.16M |
| 4 |
OXFD
Oxford Immunotec Global PLC Ordinary Shares
OXFD
|
+$3.02M |
| 5 |
FOLD
Amicus Therapeutics
FOLD
|
+$2.93M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TTPH
Tetraphase Pharmaceuticals, Inc.
TTPH
|
+$2.97M |
| 2 |
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
|
+$2.9M |
| 3 |
VOLC
VOLCANO CORPORATION COM STK
VOLC
|
+$2.74M |
| 4 |
PTX
Pernix Therapeutics Holdings, Inc.
PTX
|
+$2.42M |
| 5 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
+$2.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 80.05% |
| 2 | Consumer Discretionary | 2.48% |
| 3 | Industrials | 0.85% |
| 4 | Financials | 0% |
Similar funds
Acuta Capital Partners's Q1 2015 Portfolio in Review
As of Q1 2015, Acuta Capital Partners held 88 positions worth $119M, down 20% from $148M the previous quarter. Its ten largest holdings account for 54% of the portfolio.
Acuta Capital Partners withdrew a net $43.3M in Q1 2015, closing 37 positions and reducing 14 holdings. Its most notable exit was Tetraphase Pharmaceuticals, Inc., an estimated $2.97M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 80% of assets, up from 48% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Acuta Capital Partners opened a new position in Iovance Biotherapeutics worth $8.1M.
- Acuta Capital Partners's largest Q1 2015 buy was Iovance Biotherapeutics: 669,196 shares worth $8.1M.
- Acuta Capital Partners added most to Amicus Therapeutics in Q1 2015, an estimated $2.93M increase.
- Acuta Capital Partners's biggest Q1 2015 reduction was Pernix Therapeutics Holdings, Inc., cutting an estimated $2.42M.
- Acuta Capital Partners fully exited Tetraphase Pharmaceuticals, Inc. in Q1 2015, selling an estimated $2.97M.
- Acuta Capital Partners's ten largest holdings make up 54% of its $119M portfolio in Q1 2015.
- Acuta Capital Partners opened 24 new positions and closed 37 in Q1 2015.
- Acuta Capital Partners's portfolio value fell 20% quarter-over-quarter to $119M.
Based on Acuta Capital Partners's 13F filing for Q1 2015, filed 15 May 2015.